surmount 4 tirzepatide ECO 2026: SURMOUNT-MAINTAIN proves sustains weight loss long term Stopping Tirzepatide Leads to Rebound

It reduces gastrointestinal motility, impeding the emptying of the stomacha function that keeps the patient feeling fuller for longer

A word of caution Evidence suggests you should not use Mounjaro alongside DPP-4 (dipeptidyl peptidase-4) inhibitors, such as Januvia (generic name: sitagliptin)

Most patients in trials started at 2.5 mg weekly a low introductory dose meant to help the body adjust

Thyroid tumors: Watch for a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath

The Alzheimer's treatment space reached a breakthrough over the last year, with two newly cleared drugs proven to slow disease progression by targeting a toxic protein in the brain called amyloid, a hallmark of the condition

3 If A1C goals are not achieved after 3 months of dual therapy, triple therapy is subsequently recommended